Foehr David sold $18K of CBLL
Foehr David (Senior VP, Finance and PAO) sold 987 shares of Ceribell, Inc. (CBLL) at $18.00 on 2026-05-21 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Because the trade is explicitly under a 10b5-1 plan, it generally reduces the likelihood that the sale is reacting to newly available material information; therefore, fundamental repricing is unlikely absent other news.
Market read
Insider selling disclosure for CBLL with a 10b5-1 plan; typically low trading impact unless corroborated by broader negative signals.
What to watch
The disclosure does not state motives; traders may want to compare with prior Form 4 patterns and total insider ownership trend rather than one transaction.
Background
The article is an SEC Form 4 insider transaction filing (open-market sale) for Ceribell, Inc. (CBLL) by an officer, executed under a pre-arranged Rule 10b5-1 plan.
Ticker impact
Ceribell (CBLL) disclosed an open-market sale by its Senior VP, Finance and PAO: 987 shares sold at $18.00 on 2026-05-21 under a 10b5-1 plan.
Limited near-term impact; any reaction is likely small and short-lived unless paired with other company-specific news.
SEC Form 4 shows a scheduled 10b5-1 sale rather than an opportunistic trade tied to new information, and the article contains no operational/financial catalysts.
Market effects
Minimal—single-insider 10b5-1 sales rarely reset sector expectations for diagnostics/biotech.
None indicated; this is company-specific insider activity.
None indicated; no international deal/regulatory development mentioned.
Counterpoint
If insiders repeatedly sell outside of 10b5-1 or at unusually high frequency, it could be interpreted as elevated risk appetite reduction—even if this specific sale is scheduled.
Key entities
- issuerCeribell, Inc.
CBLL disclosed an officer’s 10b5-1 open-market sale of 987 shares at $18.00 on 2026-05-21.
- insiderFoehr David
Senior VP, Finance and PAO; sold shares directly and reported holdings after the transaction.